ATE200735T1 - Impfstoffkonjugat - Google Patents
ImpfstoffkonjugatInfo
- Publication number
- ATE200735T1 ATE200735T1 AT96111909T AT96111909T ATE200735T1 AT E200735 T1 ATE200735 T1 AT E200735T1 AT 96111909 T AT96111909 T AT 96111909T AT 96111909 T AT96111909 T AT 96111909T AT E200735 T1 ATE200735 T1 AT E200735T1
- Authority
- AT
- Austria
- Prior art keywords
- live virus
- subject
- neutralizing
- vaccine conjugate
- antibody
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 4
- 230000003472 neutralizing effect Effects 0.000 abstract 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000036039 immunity Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Chemical Treatment Of Metals (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41603589A | 1989-10-02 | 1989-10-02 | |
US48067890A | 1990-02-15 | 1990-02-15 | |
US58685990A | 1990-09-24 | 1990-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE200735T1 true ATE200735T1 (de) | 2001-05-15 |
Family
ID=27411077
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90917281T ATE150976T1 (de) | 1989-10-02 | 1990-10-01 | Impfstoff-konjugate zur behandlung von vogelkrankheiten |
AT96111909T ATE200735T1 (de) | 1989-10-02 | 1990-10-01 | Impfstoffkonjugat |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90917281T ATE150976T1 (de) | 1989-10-02 | 1990-10-01 | Impfstoff-konjugate zur behandlung von vogelkrankheiten |
Country Status (11)
Country | Link |
---|---|
US (4) | US5397569A (de) |
EP (2) | EP0495008B1 (de) |
AT (2) | ATE150976T1 (de) |
AU (2) | AU641958B2 (de) |
BR (1) | BR9007702A (de) |
CA (1) | CA2066661C (de) |
DE (2) | DE69033728T2 (de) |
DK (2) | DK0495008T3 (de) |
ES (2) | ES2102368T3 (de) |
IL (1) | IL95867A (de) |
WO (1) | WO1991004749A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL104382A0 (en) * | 1992-01-17 | 1993-05-13 | Solvay Animal Health Inc | Vaccine containing acemannan as an adjuvant |
JPH07206705A (ja) | 1993-11-03 | 1995-08-08 | American Cyanamid Co | 生インオボ(in ovo)ワクチン |
US5807551A (en) * | 1996-04-01 | 1998-09-15 | Iowa State University Research Foundation, Inc. | Method to provide artificial passive immunity in birds |
CA2264810C (en) * | 1996-09-30 | 2010-07-27 | Embrex, Inc. | Method of producing active immunity with vaccine conjugate |
PT1212045T (pt) * | 1999-08-24 | 2016-11-22 | Abic Biological Laboratories Ltd | Composição de vacina e método de utilização da mesma |
US6592869B2 (en) | 1999-08-24 | 2003-07-15 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
US6682754B2 (en) * | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
US20030170823A1 (en) | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
EP1161953A3 (de) * | 2000-06-09 | 2004-02-04 | Akzo Nobel N.V. | IBDV Stamm für in ovo Verabreichung |
ZA200104596B (en) * | 2000-06-09 | 2001-12-06 | Akzo Nobel Nv | IBDV strain for in ovo administration. |
US7029681B2 (en) | 2002-03-08 | 2006-04-18 | Schweitzer Chemical Corporation | Multiple and multivalent DNA vaccines in ovo |
US7037506B2 (en) | 2002-03-08 | 2006-05-02 | Schweltzer Chemical Corporation Ltd. | Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry |
US7265211B2 (en) | 2002-03-22 | 2007-09-04 | Zymogenetics, Inc. | Anti-IL-TIF antibodies and methods of making |
US6729265B2 (en) * | 2002-06-27 | 2004-05-04 | Arkion Life Sciences Llc | Supplemented antibody feed to enter the circulating system of newborns |
WO2006082588A2 (en) * | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
US20080311135A1 (en) * | 2007-05-22 | 2008-12-18 | Baylor College Of Medicine | Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations |
WO2013158217A1 (en) | 2012-04-20 | 2013-10-24 | Thomas Jefferson University | Engineered antibody for inhibition of fibrosis |
WO2014110092A1 (en) * | 2013-01-08 | 2014-07-17 | Humabs Biomed Sa | Methods of generating robust passive and active immune responses |
CN103341164B (zh) * | 2013-07-19 | 2015-06-24 | 天津瑞普生物技术股份有限公司 | 一种鸡传染性法氏囊病抗原抗体复合物、制剂及制备方法 |
WO2021050701A1 (en) | 2019-09-11 | 2021-03-18 | Zoetis Services Llc | Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2518978A (en) * | 1946-09-12 | 1950-08-15 | American Cyanamid Co | Hog cholera vaccine |
DE1041214B (de) * | 1957-03-11 | 1958-10-16 | Dr Med Karl Theurer | Verfahren zur Herstellung von Impfstoffen gegen Viruserkrankungen |
US3846543A (en) * | 1963-01-02 | 1974-11-05 | Monsanto Co | Process for the separation of virus from non-viral proteins |
US3326767A (en) * | 1966-03-21 | 1967-06-20 | Abbott Lab | Avian leukosis treatment with inactivated rous sarcoma virus |
US3651213A (en) * | 1969-05-29 | 1972-03-21 | Monsanto Co | Method for the immunization of a living animal body against viral disease |
US3853467A (en) * | 1973-08-15 | 1974-12-10 | Gen Electric | Method and apparatus for immunological detection of biological particles |
CA1039649A (en) * | 1973-08-30 | 1978-10-03 | General Electric Company | Method of forming multilayer immunologically complexed films |
JPS57136528A (en) * | 1981-02-09 | 1982-08-23 | Hayashibara Biochem Lab Inc | Preparation of viral vaccine |
EP0073856A1 (de) * | 1981-08-28 | 1983-03-16 | Gist-Brocades N.V. | Impfstoff gegen ansteckende Bronchitis bei Geflügel, kombinierte Impfstoffe gegen ansteckende Bronchitis, Verfahren zu deren Herstellung, Verfahren zur Vorbeugung der ansteckenden Bronchitis und Virenstamm der ansteckenden Bronchitis |
US4458630A (en) * | 1982-06-22 | 1984-07-10 | The United States Of America As Represented By The Secretary Of Agriculture | Disease control in avian species by embryonal vaccination |
US4493825A (en) * | 1982-10-05 | 1985-01-15 | Iowa State University Research Foundation | Purified and antigenically selective vaccines for domestic animals |
US4530831A (en) * | 1982-11-02 | 1985-07-23 | Akzo N.V. | Infectious Bursal Disease vaccine |
US4614793A (en) * | 1983-10-14 | 1986-09-30 | Merck & Co., Inc. | Hepatitis A--subunit antigen |
US4743562A (en) * | 1984-08-21 | 1988-05-10 | The Board Of Trustees Of The Leland Stanford Junior University | Purified human cytomegalovirus protein |
US4824668A (en) * | 1987-03-09 | 1989-04-25 | Sterwin Laboratories Inc. | Attenuated infectious bursal disease virus strain and vaccine therefrom |
US4956452A (en) * | 1987-06-14 | 1990-09-11 | The University Of Maryland | Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus |
US4867975A (en) * | 1988-01-27 | 1989-09-19 | University Of Delaware | Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof |
US5057314A (en) * | 1988-09-30 | 1991-10-15 | Whitfill Craig E | Low molecular weight antiviral factors |
-
1990
- 1990-10-01 WO PCT/US1990/005580 patent/WO1991004749A1/en unknown
- 1990-10-01 AT AT90917281T patent/ATE150976T1/de active
- 1990-10-01 AU AU67559/90A patent/AU641958B2/en not_active Ceased
- 1990-10-01 ES ES90917281T patent/ES2102368T3/es not_active Expired - Lifetime
- 1990-10-01 ES ES96111909T patent/ES2158200T3/es not_active Expired - Lifetime
- 1990-10-01 DE DE69033728T patent/DE69033728T2/de not_active Expired - Lifetime
- 1990-10-01 AT AT96111909T patent/ATE200735T1/de not_active IP Right Cessation
- 1990-10-01 AU AU67142/90A patent/AU6714290A/en not_active Abandoned
- 1990-10-01 EP EP90917281A patent/EP0495008B1/de not_active Expired - Lifetime
- 1990-10-01 DK DK90917281.9T patent/DK0495008T3/da active
- 1990-10-01 CA CA002066661A patent/CA2066661C/en not_active Expired - Lifetime
- 1990-10-01 BR BR909007702A patent/BR9007702A/pt not_active Application Discontinuation
- 1990-10-01 EP EP96111909A patent/EP0755684B1/de not_active Expired - Lifetime
- 1990-10-01 DE DE69030383T patent/DE69030383T2/de not_active Expired - Lifetime
- 1990-10-01 DK DK96111909T patent/DK0755684T3/da active
- 1990-10-02 IL IL9586790A patent/IL95867A/en not_active IP Right Cessation
-
1993
- 1993-01-25 US US08/008,394 patent/US5397569A/en not_active Expired - Lifetime
-
1996
- 1996-08-21 US US08/697,268 patent/US5871748A/en not_active Expired - Fee Related
-
1998
- 1998-01-27 US US09/013,760 patent/US6136319A/en not_active Expired - Fee Related
-
2000
- 2000-07-11 US US09/613,611 patent/US6299874B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0495008B1 (de) | 1997-04-02 |
US6299874B1 (en) | 2001-10-09 |
AU6755990A (en) | 1991-04-28 |
DK0755684T3 (da) | 2001-08-20 |
AU6714290A (en) | 1991-04-28 |
US5397569A (en) | 1995-03-14 |
ES2102368T3 (es) | 1997-08-01 |
US6136319A (en) | 2000-10-24 |
CA2066661A1 (en) | 1991-04-03 |
DE69030383D1 (de) | 1997-05-07 |
DE69030383T2 (de) | 1997-10-23 |
EP0755684B1 (de) | 2001-04-25 |
EP0495008A1 (de) | 1992-07-22 |
WO1991004749A1 (en) | 1991-04-18 |
ATE150976T1 (de) | 1997-04-15 |
US5871748A (en) | 1999-02-16 |
AU641958B2 (en) | 1993-10-07 |
IL95867A0 (de) | 1991-07-18 |
DE69033728T2 (de) | 2001-11-22 |
CA2066661C (en) | 2001-05-08 |
ES2158200T3 (es) | 2001-09-01 |
DK0495008T3 (da) | 1997-10-13 |
IL95867A (en) | 1994-10-07 |
BR9007702A (pt) | 1992-08-18 |
EP0495008A4 (en) | 1993-05-05 |
EP0755684A1 (de) | 1997-01-29 |
DE69033728D1 (de) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69033728D1 (de) | Impfstoffkonjugat | |
DK0466037T3 (da) | Fremgangsmåde til fremstilling af et gærglucan | |
YU48250B (sh) | Postupak za pripremanje aktivne vakcine protiv lajmske bolesti | |
EA199900342A1 (ru) | Способ создания активного иммунитета вакцинным конъюгатом | |
LU91396I2 (fr) | "La combinaison de la protéine L1 recombinante du papillomavirus humain de types 6,11,16 et 18" -Gardasil/Silgard | |
ATE295895T1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
LU91323I2 (fr) | Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé).-silgard | |
FI910497A0 (fi) | Nytt virus vid infektioes bursalsjukdom. | |
DE69030099T2 (de) | Verfahren zur herstellung von impfstoffen oder toxoiden | |
DE3889581T2 (de) | Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung. | |
DE69333730D1 (de) | Impfstoff, der acemannan als adjuvans enthält | |
ATE142262T1 (de) | Gegen das menschliche immunschwäche-virus gerichtetes immunpräparat | |
NZ235474A (en) | Virus capable of inducing infectious bursal disease; assay and vaccine | |
ATE39055T1 (de) | Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit. | |
KR920007636A (ko) | 신규의 백신체 | |
SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов | |
Epstein | The Vaccine Control of Virus-Induced Cancers | |
CS578887A1 (en) | Inactivated antigen of cattle's mucosal disease's virus | |
SE8701294D0 (sv) | Hiv-peptid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |